Fact checked byShenaz Bagha

Read more

August 26, 2022
4 min read
Save

Routine depression screening in primary care reduces disparities

Fact checked byShenaz Bagha
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways

  • Barriers to depression screening in primary care include patients underreporting symptoms and stigma concerns, but implementing routine screening may address these challenges.
  • Just 2 years after implementing a routine screening policy, depression screening rates in a California health system’s primary care practices jumped from 40.5% to 88.8%.
  • By the end of 2019, the researchers found that screening rates by sex were similar, but men continued to face lower odds of being screened (adjusted OR = 0.87; 95% CI, 0.81-0.93).
Perspective from Rita K. Kuwahara, MD, MIH

Implementing routine depression screening in primary care substantially increased screening rates, particularly among those at risk for undertreatment, according to a study published in JAMA Network Open.

Specifically, a routine screening policy improved screening disparities for older patients, those who are Black and those with language barriers. However, disparities for men still were present, according to researchers.

PC0822Garcia_Graphic_01_WEB
Data derived from: Garcia, M, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.27658.

“Depression screening is necessary, but not sufficient, to decrease depression care disparities,” they wrote. “Screening may help with poor physician recognition of depressive symptoms, but screening must be followed by clinical action.”

With low depression screening rates in primary care settings and recent pushes for behavioral health integration, Maria E. Garcia, MD, MPH, MAS, a clinician investigator and assistant professor of medicine at the University of California, San Francisco, and colleagues conducted the cohort study to better understand if implementing routine depression screening in primary care practices is associated with better screening rates for people who are at risk.

The researchers analyzed health record data from 52,944 adults at six University of California, San Francisco, primary care facilities who were seen from September 2017 through December 2019. They evaluated the likelihood of being screened with annual logistic regression models, and assessed comorbidities, race, ethnicity, language, sex and age for multivariable analysis.

Medical assistants conducted the screening by giving patients the Patient Health Questionnaire-2 — “a well-validated and widely used measure to screen for current depressive symptoms,” Garcia and colleagues wrote. If the results were positive for depression, the patients were asked to complete a more in-depth survey, the PHQ-9. When appropriate, clinicians could then arrange follow-up visits, initiate medication or refer the patient to a behavioral health team, social worker or psychiatrist.

In the rollout period before the intervention — from September 2017 to December 2017 — 40.5% of eligible patients were screened. In the following years, the screening rate jumped to 71.4% in 2018 (24,684 of 34,555 patients; 95% CI, 71-71.9) and 88.8% in 2019 (32,848 of 36,974 patients; 95% CI, 88.5-89.1). When the screening was fully implemented in the primary care settings, “the substantial disparities in depression screening observed early in the rollout period, which were consistent with disparities reported in prior studies, were greatly reduced,” Garcia and colleagues wrote.

During the first full year of screening for depression in 2018, the researchers wrote that “there were statistically significant differences in screening by sex, age, language-race-ethnicity group, and health insurance type.”

Compared with white, English-speaking patients, the researchers found that patients who preferred Chinese language had lower odds of being screened for depression (adjusted OR = 0.59; 95% CI, 0.51-0.67). Further, patients who spoke languages other than English, Chinese or Spanish were least likely to receive depression screening (aOR = 0.55; 95% CI, 0.47-0.64), but “screening was lower for all groups with non-English language preference compared with language-race-ethnicity groups with English language preference,” the researchers wrote.

The next year, however, the researchers found “a steady decrease in screening differences” in the secondary analysis evaluating age, sex, language-race-ethnicity and more, “resulting in resolution or near resolution of disparities by the last two quarters of 2019.” The screening rose for every group studied, “regardless of sex, language-race-ethnicity group, age, or health insurance type,” Garcia and colleagues wrote. By the end of 2019, the researchers found that screening rates by sex “were nearly identical,” but men continued to face lower odds of being screened (aOR = 0.87; 95% CI, 0.81-0.93).

The disparities for people with non-English language preferences were also “no longer significantly different than among patients with English preference” in 2019, according to the researchers.

“Through implementation of adult depression screening in primary care, a large academic health system achieved high rates of depression screening among all patients, including groups at risk for underrecognition and undertreatment of depression,” they wrote.

There are multifactorial barriers to depression screening in primary care, according to Garcia and colleagues. These include time pressures, competing demands, patients underreporting symptoms and stigma concerns. Implementing routine screening eased some of these barriers, though, the researchers wrote.

“Several factors may have contributed to achieving high, more equitable screening rates in this health system,” the researchers wrote.

For example, the health care system in the study was able to provide the primary care practices with the support and resources they needed for the program. Depression screening was a priority for the system due to “a larger focus on quality improvement metrics implemented across safety net systems in California that are tied to state funds,” Garcia and colleagues wrote. The practices also benefited from a task force that the health system convened that focused specifically on identifying screening disparities and making adjustments.

Further, according to the researchers, the seamless alignment of depression screening with established clinical workflows in 2018 “likely contributed to increasing screening rates” the following year. Having access to professional interpreters and the fact that the screening tool was available in multiple languages “may have facilitated implementation,” they added.

“This alignment of local quality improvement efforts, health system priorities, reimbursement policies, and a health equity lens for improvement efforts created a favorable environment to implement and improve adult depression screening in these primary care practices,” the researchers wrote.

In all, the researchers concluded that with the well-documented disparities in depression care for underrepresented populations, “a focus on implementing depression screening and initial depression treatment in primary care may help to improve depression recognition and appropriate treatment for all patients.”